MapMyGenome

Hyderabad, India Founded: 2013 • Age: 13 yrs Minicorn
Personal genetic testing and diagnostics services are provided.

About MapMyGenome

MapMyGenome is a Healthcare company based in Hyderabad (India) founded in 2013 by Subash Lingareddy and Anu Acharya. Personal genetic testing and diagnostics services are provided. MapMyGenome has raised $1.69 million across 4 funding rounds from investors including CMS Computers, Currae Healthtech Fund and R Gopala Krishnan. The company has 87 employees. MapMyGenome has completed 1 acquisition, including Microbiome Insights. MapMyGenome was last valued at $8.91 million in December 2019. Its chief executive, as recorded, is Anu Acharya. Its website mapmygenome.in draws about 68 thousand monthly visits. Its Indian entity Mapmygenome India Limited reported revenue of ₹31.20 Cr. MapMyGenome offers products and services including Genomepatri, MapmyBiome, Medicamap, and Genomepatri Heritage. Its focus areas include HealthTech, Healthcare Booking Platforms, Diagnostics and Internet First Clinical Labs. Its competitors include Bione, Xcode Life and StellarGene; 1 of its 3 listed competitors has raised funding.

Company details

MapMyGenome was established in 2013 in Hyderabad, India, by the founders of Ocimum BioSolutions as a privately held entity in the personal genomics and biotechnology sector. Genetic testing is offered to customers, with data organized and analyzed for insights. Counseling is provided to interpret results. Operations include user registration, sample collection, laboratory processing, data analysis, report generation, and genetic counseling sessions.

  • Headquarters Hyderabad, India
  • Employees 87
  • Founders Subash Lingareddy, Anu Acharya
  • Stage Minicorn
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website mapmygenome.in
  • Social LinkedIn X Facebook Instagram YouTube
  • Legal Name Mapmygenome India Limited
  • Date of Incorporation 10 Feb, 2012
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹31.20 Cr

    FY 2025 · +2% YoY

  • Net Profit
    ₹1.80 Cr

    FY 2025 · 6% margin

  • EBITDA
    ₹4.83 Cr

    FY 2025 · 15% margin

  • Total Equity Funding
    $1.69M (USD)

    in 4 rounds

  • Latest Funding Round
    $270.72K (USD), Angel Round

    Dec 2019

  • Investors
  • Employee Count
    87
  • Investments & Acquisitions

Products & Services of MapMyGenome

MapMyGenome offers a comprehensive portfolio of products and services, including Genomepatri, MapmyBiome, Medicamap, and Genomepatri Heritage.

Genomepatri
DNA Test

At-home test for health and wellness genetic insights

MapmyBiome
Microbiome Test

Analysis of gut microbiome for digestion and energy

Medicamap
Pharmacogenomics Test

Test for personalized medication responses

Genomepatri Heritage
Ancestry Test

Genetic analysis for ancestry and origins

Apps and channels of MapMyGenome

its YouTube channel MapmyGenome has 20.8K subscribers and 30 videos.

MapmyGenome
YouTube 20.8K subscribers 30 videos Howto & Style
Open channel

Videos from MapMyGenome

The most watched videos on MapMyGenome's YouTube channel, MapmyGenome (20.8K subscribers). Click a video to play it here.

Do social relationships affect your gut microbiome
98.1K views
Lactose Intolerant? Here’s What Happens After Drinking Lassi 🥛😖
6K views
Genetics Before Birth: Dr. Ashwin Dalal on Prenatal & Pediatric Genetics | Genomics Gupshup Ep #53
670 views
🧬 Why Your Gut Health May Depend on Your Genes?
600 views

More on MapmyGenome.

Funding Insights of MapMyGenome

MapMyGenome has successfully raised a total of $1.69M across 4 strategic funding rounds. The most recent funding activity was a Angel Round of $270.72 thousand completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.69M
  • Total Rounds 4
  • Last Round Angel Round — $270,721
  • First Round $1.1M

    (Feb 2015)

  • Investors Count 23

All 4 funding rounds of MapMyGenome with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2019$270,721Angel Round$8.91MArjun Malhotra, M Vidyasagar
Mar 2018$198,947Angel Round$9.42MRatan N Tata
–
Sep 2017$116,413Seed$•••••Singapore Angel Network
Feb 2015$1.1MSeed$•••••Mayur M Desai
Valuation history
DateValuationStage
Dec 2019$8.91M••••••••
Mar 2018$9.42M••••••••
Sep 2017$•••••••••••••
Feb 2015$•••••••••••••
Premium access

Full valuation and stage history of MapMyGenome

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $8.91M (Dec 2019). 23 investors in total: 3 institutional and 20 angel.

Investors in MapMyGenome

MapMyGenome has secured backing from 23 investors, including angel, institutional, and venture fund investors. Prominent investors backing the company include CMS Computers, Currae Healthtech Fund and R Gopala Krishnan.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Angel network focused on India, Singapore, and U.S based companies
sgan.sgSingapore, Singapore
Venture capital funding and support for healthtech startups.
2015curraehealthtech.comMumbai, India
IT services and specialized solutions are provided by CMS.
1976cms.co.inMumbai, India

R Gopala Krishnan

unknown_3f3101aa77c2436fa

Arjun Malhotra

Co-founder of HCL Technologies, prominent angel investor, tech visionary
unknown_5ef11f82214643e98

M Vidyasagar

unknown_c992186a85764b81a

Ratan N Tata

Chairman Emeritus of Tata Sons, iconic industrialist, and active angel investor
unknown_7bd38f375faf4e789

Rajan Anandan

Managing Director at Peak XV, ex-Google India head, prolific angel investor
unknown_2969590774304595b

Vaidyanath Balasubramanian

unknown_b67ba16c6bf1492fa

Hemant Hansraj

unknown_b54375646903489e8
Premium access

Investor details for MapMyGenome

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Mapmygenome India Limited (MapMyGenome)

Mapmygenome India Limited is the primary company behind MapMyGenome. The board of Mapmygenome India Limited currently have 4 directors; the longest-serving is Arjun Malhotra, appointed in 2013. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Arjun Malhotra
DIN 00177397
Director16 Apr 201313 yrs 6 moMapmygenome India Limited
Anuradha Acharya
DIN 00125335
Director20 Apr 201313 yrs 6 moMapmygenome India Limited
Ramabadran Gopalakrishnan
DIN 00027858
Director01 Feb 20179 yrs 8 moMapmygenome India Limited
Venkata Subash Lingareddy
DIN 00125240
Additional Director14 Mar 20242 yrs 7 moMapmygenome India Limited

People of MapMyGenome

31 people are tracked at MapMyGenome (9 in leadership, 11 in board & advisors, 11 in team); the tracked headcount is 87.

NameRoleGroup
Co-FounderLeadership
Anu Acharya
Co-Founder & CEOLeadership
Naveen Talwar
CMOLeadership
Praveen Parvathaneni
VP & Head of AlliancesLeadership
Udbhav Relan
VP, Product & Business StrategyLeadership
George K John
Head IT, Network & Data SecurityLeadership
Sandhya Kiran Pemmasani
VP, BioinformaticsLeadership
Sanjay Kumar
Head Of HRLeadership
Neeraja Reddy Malleda
VP, Genetic CounselingLeadership
Anula Jayasuriya
DirectorBoard & advisors
Ravi N. Bathina
AdvisorBoard & advisors
K Thangaraj
AdvisorBoard & advisors
Jai Prakash Mehta
AdvisorBoard & advisors
Radha Rama Devi
AdvisorBoard & advisors
Mathukumalli Vidyasagar
AdvisorBoard & advisors
Partha Pratim Majumder
AdvisorBoard & advisors
R Gopalakrishnan
ChairmanBoard & advisors
Sharon Terry
AdvisorBoard & advisors
M. Vidyasagar FRS
Head of Scientific AdvisorBoard & advisors
DirectorBoard & advisors

11 more people are available in the full profile.

Premium access

Complete people profiles for MapMyGenome

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of MapMyGenome

Figures of Mapmygenome India Limited, the primary company behind MapMyGenome, for FY 2025. Revenue was ₹31.20 Cr (+2% year on year). Net profit was ₹1.80 Cr (6% margin). EBITDA was ₹4.83 Cr (15% margin). Revenue has grown at a compounded annual rate of -35% over three years and +30% over five years.

  • ₹31.20 CrRevenue · FY 2025 · +2% YoY
  • ₹1.80 CrNet profit · 6% margin
  • ₹4.83 CrEBITDA · 15% margin
  • ₹3.44 CrPaid-up capital
  • 87Employees (provident fund records)
  • -35%Revenue CAGR, 3 years
  • +30%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Mapmygenome India Limited are on its company page.

Premium access

Detailed financial statements for MapMyGenome

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by MapMyGenome

MapMyGenome has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Microbiome Insights.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Microbiome analysis solutions are provided for academic and industrial researchers.
microbiomeinsights.comVancouver, Canada2015May 2025••••
Premium access

Complete acquisition details for MapMyGenome

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of MapMyGenome

5 dated milestones of MapMyGenome across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded MapMyGenome is founded.
  2. Funding First funding round of $1.1M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Angel Round, of $271K.
  5. Acquisition Acquires Microbiome Insights.

Competitors of MapMyGenome

MapMyGenome has 3 listed competitors in our database, 1 of them funded. They include Bione, Xcode Life and StellarGene.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bione.in2019Bengaluru, India27
Diagnostic kits for microbiome testing are developed to manage health.
xcode.in2010Chennai, India$2.5M
Provider of personalized health and wellness solutions
stellargene.com2016Delhi, India
Provides comprehensive genetic testing solutions for accurate gene analysis and personalized health insights.
Premium access

Detailed competitors of MapMyGenome

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of MapMyGenome

The website of MapMyGenome (mapmygenome.in) receives about 67.6K visits a month.

  • Monthly visits
    67.6K

    ▲ 40% vs previous month

Similar websites

Websites whose visitors overlap most with MapMyGenome. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
dnalabsindia.com
100%
34.3K#942,323View details
dnaforensics.in
83%
3.7K#5,323,955View details
auromere.com
80%
680.7K#1,486,737View details
mapmygene.com
74%
#8,021,007View details
indushealthplus.com
74%
30.1K#974,119View details
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 40 similar websites and full traffic analytics for MapMyGenome

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Mapmygenome

Premium access

Complete news archive for MapMyGenome

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MapMyGenome

MapMyGenome was founded in 2013 and raised its 1st funding round 2 years after it was founded.

MapMyGenome is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Anu Acharya is the CEO of MapMyGenome, as recorded in our data. They have also founded this company.

MapMyGenome is a funded company, having raised a total of $1.69M across 4 funding rounds to date. The company's 1st funding round was a Seed of $1.1M, raised on Feb 2015.

MapMyGenome has 87 employees.

The primary company behind MapMyGenome, Mapmygenome India Limited, reported revenue of ₹31.20 Cr for FY 2025, up 2% year on year.

MapMyGenome was established in 2013 in Hyderabad, India, by the founders of Ocimum BioSolutions as a privately held entity in the personal genomics and biotechnology sector. Genetic testing is offered to customers, with data organized and analyzed for insights. Counseling is provided to interpret results. Operations include user registration, sample collection, laboratory processing, data analysis, report generation, and genetic counseling sessions.

MapMyGenome's top competitors include Bione, Xcode Life and StellarGene.

MapMyGenome offers Genomepatri, MapmyBiome, Medicamap, and Genomepatri Heritage.

MapMyGenome has made 1 acquisition, including Microbiome Insights.

MapMyGenome has 23 investors. Key investors include CMS Computers, Currae Healthtech Fund, R Gopala Krishnan, Arjun Malhotra, and M Vidyasagar.

The valuation of MapMyGenome is $8.91M as of Dec 2019.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available